Internal Medicine, Pulmonary Disease · Punta Gorda, FL
NPI
1972605434
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
25086 Olympia Ave, Suite 300
Punta Gorda, FL, 33950
Phone (941) 205-5300
Groups this clinician bills Medicare through
Medicare paid, 2024
$565K
5,838 services
Medicare patients, 2024
1,840
Average age 76
Drug cost, 2024
$1.7M
2,070 prescriptions
Company payments, 2025
$2,495
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fabrizio Monge was code 99214 (office e&m - established), 1,401 times for 804 patients. In total Fabrizio Monge billed 5,838 services in 36 codes, and Medicare paid $565K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-12-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,401 | 804 | $96.91 | $136K |
| 94727 Pulmonary Function Testing | Office | 450 | 424 | $34.31 | $15K |
| 99291 Critical Care E&M | Facility | 450 | 239 | $176.68 | $80K |
| 94729 Pulmonary Function Testing | Office | 450 | 424 | $42.93 | $19K |
| 99454 E&M - Miscellaneous | Office | 434 | 158 | $37.77 | $16K |
| 99213 Office E&M - Established | Office | 371 | 320 | $66.71 | $25K |
| 99233 Hospital E&M - Subsequent | Facility | 347 | 205 | $98.83 | $34K |
| 99232 Hospital E&M - Subsequent | Facility | 310 | 214 | $65.79 | $20K |
| 94010 Pulmonary Function Testing | Office | 289 | 278 | $21.31 | $6,158 |
| 99204 Office E&M - New | Office | 273 | 273 | $128.76 | $35K |
| 94664 E&M - Miscellaneous | Office | 186 | 167 | $14.39 | $2,676 |
| 94060 Pulmonary Function Testing | Office | 164 | 155 | $30.15 | $4,944 |
| 95811 Sleep Study | Office | 150 | 147 | $504.14 | $76K |
| 99223 Hospital E&M - Initial | Facility | 129 | 124 | $138.84 | $18K |
| 95810 Sleep Study | Office | 117 | 116 | $494.57 | $58K |
By year: 2022 $563K for 6,537 services; 2023 $627K for 6,664 services; 2024 $565K for 5,838 services.
Medicare prescription drug claims, 2024
In 2024, the drug Fabrizio Monge prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 559 prescriptions and refills. In total Fabrizio Monge wrote 2,070 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 559 | 1,090 | 166 | $682K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 389 | 451 | 153 | $11K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 201 | 334 | 68 | $204K |
| Prednisone Generic | 130 | 168 | 83 | $480 |
| Breo Ellipta Fluticasone/Vilanterol | 115 | 226 | 33 | $88K |
| Azithromycin Generic | 108 | 152 | 78 | $938 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 75 | 154 | 19 | $70K |
| Montelukast Sodium Generic | 66 | 188 | 25 | $729 |
| Ventolin Hfa Albuterol Sulfate | 51 | 57 | 27 | $3,003 |
| Ofev Nintedanib Esylate | 39 | 39 | Under 11 | $505K |
| Fluticasone Propionate Generic | 20 | 48 | 12 | $579 |
| Ropinirole Hcl Generic | 19 | 31 | Under 11 | $359 |
| Levofloxacin Generic | 19 | 19 | 17 | $122 |
| Ipratropium Bromide Generic | 19 | 21 | Under 11 | $617 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 18 | 18 | 15 | $126 |
Brand drugs: 1,404 claims; generic drugs: 666 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fabrizio Monge $2,495 ($2,495 in general payments such as food, travel and fees) from 22 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $590.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 20 | $590 |
| GlaxoSmithKline, LLC. GSK | 27 | $509 |
| Genzyme Corporation SNY | 7 | $189 |
| Insmed, Inc. INSM | 7 | $177 |
| Grifols USA, LLC | 11 | $166 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $136 |
| Verona Pharma, Inc. VRNA | 5 | $105 |
| ANI Pharmaceuticals, Inc. ANIP | 3 | $100 |
| Merck Sharp & Dohme LLC MRK | 3 | $79.77 |
| Viatris Specialty LLC | 3 | $66.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.